Overview

AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the safety and efficacy of switching to Azarga from prior pharmacotherapy in patients with open-angle glaucoma.
Phase:
Phase 4
Details
Lead Sponsor:
Alcon Research
Treatments:
Brinzolamide
Ophthalmic Solutions
Tetrahydrozoline
Timolol